Literature DB >> 7548229

Fibroblasts co-expressing tyrosinase and the b-protein synthesize both eumelanin and phaeomelanin.

A J Winder1, G Odh, E Rosengren, H Rorsman.   

Abstract

Melanin synthesis in the mouse involves the interaction of many pigmentation loci. Tyrosinase, the product of the albino (c) locus, catalyses the first step of the pathway. The brown (b) locus protein has significant homology to tyrosinase and controls black/brown coat coloration, but its function is controversial. To investigate the function of the b-protein and its interaction with tyrosinase, we established cell lines expressing both tyrosinase and the b-protein by transfecting tyrosinase-expressing fibroblasts with a b-protein expression vector. The tyrosinase-expressing parent line does not have L-dopachrome tautomerase activity, but this enzyme is detectable in double transfectants as well as in fibroblasts expressing the b-protein alone. Cells expressing both proteins have a higher steady-state level of tyrosinase than fibroblasts expressing tyrosinase alone, and contain elevated levels of melanin intermediates. This is thought to result from interaction of tyrosinase with the b-protein. Only phaeomelanin is detectable in fibroblasts expressing tyrosinase alone, whereas double transfectants synthesise significantly more phaeomelanin and detectable eumelanin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7548229     DOI: 10.1016/0167-4889(95)00089-b

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Complete sequence and polymorphism study of the human TYRP1 gene encoding tyrosinase-related protein 1.

Authors:  N F Box; J R Wyeth; C J Mayne; L E O'Gorman; N G Martin; R A Sturm
Journal:  Mamm Genome       Date:  1998-01       Impact factor: 2.957

2.  Minimal Efficacy of Nitisinone Treatment in a Novel Mouse Model of Oculocutaneous Albinism, Type 3.

Authors:  Ighovie F Onojafe; Lucyanne H Megan; Madeline G Melch; Joseph O Aderemi; Ramakrishna P Alur; Mones S Abu-Asab; Chi-Chao Chan; Isa M Bernardini; Jessica S Albert; Tiziana Cogliati; David R Adams; Brian P Brooks
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-10-01       Impact factor: 4.799

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.